Skip to content
DataLookout
Menu

QZDC-PONCT07895082

Quanduzhong Capsules for Primary Osteoporosis

StatusEnrolling by Invitation
PhasePhase 3
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Notable Start date pushed from Oct 15, 2026 to Dec 15, 2026
    • Study sites: 1 to 3
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Change in bone mineral density (BMD) of the lumbar spine (L1-L4)
Timeframe: Baseline and 6 months

Secondary (11)

Change in Serum Calcium
Change in Serum Phosphorus
Change in muscle strength
Change in incidence of falls
Change in 25-Hydroxyvitamin D
Show 6 moreShow less
Change in Parathyroid Hormone (PTH)
Change in Serum P1NP
Change in Serum CTX
Change in Serum Osteocalcin
Change in Bone Mineral Density (BMD) of the Femoral Neck and Total Hip
Change in T-score at the Femoral Neck and Total Hip

Arms and interventions

Quan Duzhong CapsulesExperimental

Quan Duzhong Capsules (Du-Zhong) are administered orally, 3 capsules per dose, twice daily, taken with warm water after meals, for 6 consecutive months. All participants also receive a calcium and vitamin D3 preparation (Liquan Calcium Carbonate and Vitamin D3 Tablets, each tablet containing calcium 600 mg and vitamin D3 125 IU), oral administration, 1 tablet per dose, once daily, taken with warm water 10 minutes after dinner, for 6 consecutive months.

PlaceboPlacebo comparator

Quan Duzhong Capsule placebo, oral, 3 capsules twice daily after meals, plus Calcium Carbonate and Vitamin D3 Tablets, oral, 1 tablet once daily 10 minutes after dinner, for 6 consecutive months.

Drugs: Quan Duzhong Capsules, Quan Duzhong Capsule Placebo

Sites

3 sites in 1 country